383 related articles for article (PubMed ID: 17030285)
1. Vaginal microbicides.
O'Brien RF
Adolesc Med Clin; 2006 Oct; 17(3):673-85; abstract xi. PubMed ID: 17030285
[TBL] [Abstract][Full Text] [Related]
2. The impact of microbicides and changes in condom usage on HIV prevalence in men and women.
Chen FH
AIDS; 2006 Jul; 20(11):1551-3. PubMed ID: 16847411
[TBL] [Abstract][Full Text] [Related]
3. Desired qualities and hypothetical contextual use of vaginal microbicides in a diverse sample of US women.
Olsen ML; Cwiak CA; Koudelka C; Jensen JT
Contraception; 2007 Oct; 76(4):314-8. PubMed ID: 17900444
[TBL] [Abstract][Full Text] [Related]
4. Microbicides: a new frontier in HIV prevention.
McGowan I
Biologicals; 2006 Dec; 34(4):241-55. PubMed ID: 17097303
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology of new HIV infections and interventions to limit HIV transmission.
Buchbinder S
Top HIV Med; 2009; 17(2):37-43. PubMed ID: 19401606
[TBL] [Abstract][Full Text] [Related]
6. Microbicide preference among young women in California.
Holt BY; Morwitz VG; Ngo L; Harrison PF; Whaley KJ; Pettifor A; Nguyen AH
J Womens Health (Larchmt); 2006 Apr; 15(3):281-94. PubMed ID: 16620187
[TBL] [Abstract][Full Text] [Related]
7. Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets.
Garg S; Goldman D; Krumme M; Rohan LC; Smoot S; Friend DR
Antiviral Res; 2010 Dec; 88 Suppl 1():S19-29. PubMed ID: 21109064
[TBL] [Abstract][Full Text] [Related]
8. Microbicidal spermicide or spermicidal microbicide?
Gupta G
Eur J Contracept Reprod Health Care; 2005 Dec; 10(4):212-8. PubMed ID: 16448947
[TBL] [Abstract][Full Text] [Related]
9. The need for a "condoms-only" control group in microbicide trials.
Jones H; van de Wijgert J; Kelvin E
Epidemiology; 2003 Jul; 14(4):505; author reply 505-6. PubMed ID: 12843779
[No Abstract] [Full Text] [Related]
10. The slow evolution of microbicides for STD/HIV prevention.
Howes J; Bass M
J Gend Specif Med; 1999; 2(3):22-3. PubMed ID: 11252848
[No Abstract] [Full Text] [Related]
11. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection.
Dhawan D; Mayer KH
J Infect Dis; 2006 Jan; 193(1):36-44. PubMed ID: 16323129
[TBL] [Abstract][Full Text] [Related]
12. Challenges to microbicide introduction in South Africa.
Orner P; Harries J; Cooper D; Moodley J; Hoffman M; Becker J; McGrory E; Dabash R; Bracken H
Soc Sci Med; 2006 Aug; 63(4):968-78. PubMed ID: 16600447
[TBL] [Abstract][Full Text] [Related]
13. Clinical development of microbicides for the prevention of HIV infection.
D'Cruz OJ; Uckun FM
Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
[TBL] [Abstract][Full Text] [Related]
14. AIDS research. Microbicide fails to protect against HIV.
Cohen J
Science; 2008 Feb; 319(5866):1026-7. PubMed ID: 18292313
[No Abstract] [Full Text] [Related]
15. The future of HIV prevention: prospects for an effective anti-HIV microbicide.
Nuttall J; Romano J; Douville K; Galbreath C; Nel A; Heyward W; Mitchnick M; Walker S; Rosenberg Z
Infect Dis Clin North Am; 2007 Mar; 21(1):219-39, x. PubMed ID: 17502237
[TBL] [Abstract][Full Text] [Related]
16. Microbicides and other topical strategies to prevent vaginal transmission of HIV.
Lederman MM; Offord RE; Hartley O
Nat Rev Immunol; 2006 May; 6(5):371-82. PubMed ID: 16639430
[TBL] [Abstract][Full Text] [Related]
17. PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity.
Keller MJ; Guzman E; Hazrati E; Kasowitz A; Cheshenko N; Wallenstein S; Cole AL; Cole AM; Profy AT; Wira CR; Hogarty K; Herold BC
AIDS; 2007 Feb; 21(4):467-76. PubMed ID: 17301565
[TBL] [Abstract][Full Text] [Related]
18. Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women.
El-Sadr WM; Mayer KH; Maslankowski L; Hoesley C; Justman J; Gai F; Mauck C; Absalon J; Morrow K; Mâsse B; Soto-Torres L; Kwiecien A
AIDS; 2006 May; 20(8):1109-16. PubMed ID: 16691061
[TBL] [Abstract][Full Text] [Related]
19. HIV trial doomed by design, say critics.
Check E
Nature; 2007 Jul; 448(7150):110-1. PubMed ID: 17625525
[No Abstract] [Full Text] [Related]
20. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
van de Wijgert JH; Kilmarx PH; Jones HE; Karon JM; Chaikummao S
Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
